Aligos Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$5.54

+0.03 (+0.54%)

As of Sep 28, 10:31 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +11.7% upside

Low Target $4.22

Average Target $6.19

High Target $8.57

Current Price $5.54

Current
$5.54

Target
$6.19

$4.22 $6.19 avg $8.57

Scenario Analysis

Bear Case

$4.22

-23.8%

Low target

Base Case

$6.19

+11.7%

Avg target

Bull Case

$8.57

+54.7%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$13.69

-59.5% from high

52-Week Low

$3.98

+39.2% from low

Target vs 52W High

$6.19

-54.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-3.3%
AMGN Amgen Inc	Hold	43	47%	$190.87	-54.4%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+138.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-16.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-89.8%
MRNA Moderna Inc	Hold	30	37%	$149.45	-24.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-43.4%